Viewing Study NCT03535961

Bugs

Ignite Creation Date: 2025-12-17 @ 1:44 PM

Ignite Modification Date: 2025-12-23 @ 8:40 PM

Study NCT ID: NCT03535961

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module